Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas

Laboratory Investigation

Volumn 78, Issue 2, 1998, Pages 165-174

  Chen, Thomas C ^a   Hinton, David R ^a   Zidovetzki, Raphael ^b   Hofman, Florence M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; GLIOMA; HUMANS; ISOENZYMES; TUMOR CELLS, CULTURED;

EID: 0031892108     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Aharoni D, Dantes A, Oren M, and Amsterdam A (1995). cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Exp Cell Res 218:271-288.
2. Ally S, Tortora G, Clair T, Grieco D, Merlo G, Katsaros D, Ogreid D, Doskeland SO, Jahnsen T, and Cho-Chung YS (1988). Selective modulation of protein kinase isozymes by the site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc Natl Acad Sci USA 85:6319-6322.
3. Beebe SJ, Holloway R, Rannels SR, and Corbin JD (1984). Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes. J Biol Chem 259:3539-3547.
4. Boe R, Gjertsen BT, Doskeland SO, and Vintermyr OK (1995). 8-chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line. Br J Cancer 72:1151-1159.
5. Boynton AL and Whitfield JF (1983). The role of cyclic AMP in cell proliferation: A critical assessment of the evidence. Adv Cyclic Nucleotide Res 15:193-294.
6. Chicoine MR and Silbergeld DL (1995). The in vitro motility of human gliomas increases with increasing grade of malignancy. Cancer 75:2904-2909.
7. Cho-Chung YS (1990). Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: New approaches to therapy. Cancer Res 50:7093-7100.
8. Cho-Chung YS, Clair T, Tagliaferri P, Ally S, Katsaros D, Tortora G, Neckers L, Avery TL, Crabtree GW, and Robins RK (1989). Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest 7:161-177.
9. Corbin JD, Rannels SR, Flockhart DA, Robinson-Steiner AM, Tigani MC, Doskeland SO, Suva RH, Suva R, and Miller JP (1982). Effect of cyclic nucleotide analogs on intrachain site 1 of protein kinase isozymes. Eur J Biochem 125:259-266.
10. Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH, and Law RE (1994). Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345:43-46.
11. Downs SM and Hunzicker-Dunn M (1995). Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate. Dev Biol 172:72-85.
12. Dumont JE, Jauniaux JC, and Roger PP (1989). The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 14:67-71.
13. Ekanger R, Ogreid D, Evjen O, Vintermyr O, Laerum OD, and Doskeland SO (1985). Characterization of cyclic adenosine 3′:5′-monophosphate-dependent protein kinase isozymes in normal and neoplastic fetal rat brain cells. Cancer Res 45:2578-2583.
14. Friedman DL (1976). The role of cyclic nucleotides in the cell cycle. Adv Cyclic Nucleotide Res 7:69-114.
15. Furman MA and Shulman K (1973). Cyclic AMP and adenyl cyclase in brain tumors. J Neurosurg 46:477-483.
16. Ikeda K, Okazaki R, Inone D, Ogata E, and Matsumoto T (1993). Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E, in HTLV-1 infected T cells. J Biol Chem 268:1174-1179.
17. Ikemoto H, Tani E, Matsumoto T, Nakano A, and Furuyama JI (1995). Apoptosis of human glioma cells in response to calphositin C, a specific protein kinase C inhibitor. J Neurosurg 83:1008-1016.
18. Lange-Carter CA, Vuillequez JJ, and Malkinson AM (1993). 8-chloroadenosine mediates 8-chloro-cyclic AMP-induced down-regulation of cyclic AMP-dependent protein kinase in normal and neoplastic mouse lung epithelial cells by a cyclic AMP-independent mechanism. Cancer Res 53:393-400.
19. Lanotte M, Riviere JB, Hermouet S, Houge G, Vintermyr OK, Gjertsen BT, and Doskeland SO (1991). Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J Cell Physiol 146:73-80.
20. Le Prince G, Fages C, Rolland B, Nunez J, and Tardy M (1991). DBcAMP effect on the expression of GFAP and of its encoding mRNA in astroglial primary cultures. Glia 4:322-326.
21. Nakano A, Tani E, Miyazaki K, Yamamoto Y, and Furuyama JI (1995). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298-307.
22. Nesternova M and Cho-Chung YS (1995). A single injection of protein kinase A-directed antisense treatment to inhibit tumour growth. Nat Med 1:528-533.
23. Ogreid D, Ekanger R, Suva RH, Miller JP, and Doskeland SO (1989). Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogs. Eur J Biochem 181:19-31.
24. Ohmura AE, Wakai K, Isozaki O, Murakami H, Onoda N, Emoto N, Shizume K, Tsushima T, Demura H, and Robins RK (1993). Inhibition of human pancreatic cancer cell line (MIA PaCa-2) growth by cholera toxin and 8-choloro-cAMP in vitro. Br J Cancer 67:279-283.
25. Pastan IH, Johnson GS, and Anderson WB (1974). Role of cyclic nucleotides in growth control. Adv Cancer Res 19:303-329.
26. Pirson I, Coulonval K, Lamy F, and Dumont JE (1996). c-Myc expression is controlled by the mitogenic cAMP-cascade in thymocytes. J Cell Physiol 168:59-70.
27. Raju TR, Bignami A, and Dahl D (1980). Glial fibrillary acidic protein in monolayer cultures of C-6 glioma cells: Effect of aging and dibutyryl cyclic AMP. Brain Res 200:225-230.
28. Roger PP, Reuse S, Maenhaut C, and Dumont JE (1995). Multiple facets of the modulation of growth by cAMP. Vitam Horm 51:59-191.
29. Salcman M (1995). Glioblastoma and malignant astrocytoma. In: Kaye AH and Laws ER, editors: Brain tumors. Edinburgh: Churchill Livingstone, 449-479.
30. Segovia J, Lawless GM, Tillakaratne NJK, Brenner M, and Tobin AJ (1994). Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglial marker (GFAP) in C6 cells. J Neurochem 63:1218-1225.
31. Spaulding SW (1993). The ways in which hormones change cyclic adenosine 3′,5′-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr Rev 14:632-650.
32. Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, Rubalcava B, Parandoosh Z, Chang Y, Revankar GR, Crabtree GW, Robins RK, and Cho-Chung YS (1988). Synergistic inhibition of growth of breast and colon human cancer lines by site-selective cyclic AMP analogues. Cancer Res 48:1642-1650.
33. Tanaka K, Iwamoto Y, Ito Y, Ishibashi T, Nakebeppu Y, Sekiguchi M, and Sugioka Y (1995). Cyclic AMP-rgulated synthesis of the tissue inhibibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res 55:2927-2935.
34. Tsai CH, Hung LM, Cheng HP, and Chen JK (1995). Increased intracellular cyclic AMP levels suppress the mitogenic repsonses of human astrocytoma cells to growth factors. J Neurooncol 23:41-52.
35. Van Lookeren M, Campagne M, Diaz FV, Jastorff B, and Kessin RH (1991). 8-Choloroadenosine 3′,5′-monophosphate inhibits the growth of Chinese hamster ovary and Molt-4 cells through its adenosine metabolite. Cancer Res 51:1600-1605.
36. 2-CAMP induce cell death independently of cAMP kinase-mediated inhibition of the G1/S transition in mammary carcinoma cells (MCF-7). Endocrinology 136:2513-2520.